Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL

Bibliographic Details
Title: Disease Kinetics Measured By Circulating Tumor DNA Correlates with Treatment Response after Tafasitamab in Combination with R-CHOP with or without Lenalidomide in First Line Treatment of DLBCL
Authors: Khouja, Mouhamad, Schilhabel, Anke, Kotrova, Michaela, Brüggemann, Monika, Kuffer, Christian, Blair, Derek, Darzentas, Nikos, Pott, Christiane
Source: In Blood 23 November 2021 138 Supplement 1:3498-3498
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood-2021-153176
Published in:Blood
Language:English